Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

  • ESTA - Electronic System for Travel Authorization
Receive Latest News

Share Us

EURO CANCER 2018 - 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology

View: 246

Website | Edit Freely

Category cancer conferences;Oncology conferences

Deadline: July 10, 2018 | Date: July 23, 2018-July 25, 2018

Venue/Country: Rome, Italy

Updated: 2018-02-01 15:16:18 (GMT+9)

Call For Papers - CFP

Conferenceseries LLC is overwhelmed to welcome all the interested participants to its 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 23-25, 2018 at Rome, Italy.

The conference will be organized around the theme: Scrutinizing Progressive Cancer Research in Diagnosis, Treatment and Prevention

Conference Title: 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology

Dates: July 23-25, 2018

Venue: Rome, Italy

Short Name: Euro Cancer 2018


Euro Cancer 2018 is an event that brings together active researchers, intellectuals, academicians, students, contributors and industrialists to exchange ideas communicate and discuss research findings on new advancements in all kinds of available cancer therapies worldwide. This Italy Cancer Congress is going to be the largest and most promising international conference that specifically focuses on the Radiation therapy by bringing all Renowned Radiation Oncologists under one roof. This is a two day multidisciplinary meeting covering all aspects of Cancer Therapies and Radiation Oncology, including clinical service delivery, management, informatics and research.

About Organisation:

ConferenceSeries LLC which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. Conferenceseries LLC has an enhanced and highlighted features of scientific partnerships and alliances with development agencies, Institutes, leading research organizations, non-government organizations, and other entities to promote the development-oriented research across the world through live streaming, B2B and Scientific Meetings. Conference Series initiated the 'Young Scientist awards' to the enterprising young science researchers and scholars across the globe.

Benefits: CME & CPD Credits

• IOCM certification, International Recognition and Collaboration,

• Can Showcase your Research work before Conferences Attendees

• Key Modules: Speaker / Delegate / Poster / Young Research forum / Video Presentation / e-Poster

• Can organise Workshops and Symposia

• Inclusion of Title of Talk in Scientific Program

• Publication of Abstract in the Conference Souvenir and also in the International Cancer Journals

• Opportunity to Chair/ Co-Chair a Session

• Opportunity to decide Best Poster Award

• Group discounts are also available

Target Audience:

Oncologists, Radiologists, Chemotherapists, Doctors, Oncology Institutes, Medical Colleges, Research faculty, Academic Scientists, Students, Cancer Diagnostics Associations and Societies, Diagnostic laboratory professionals, Business Entrepreneurs, Industry professionals, Directors/Managers/CEO, Presidents & Vice Presidents, Brand Manufacturers/ Marketers of Consumer Products, Marketing, Advertising and Promotion Agency Executives

We are hoping a positive response from you

For any queries or concerns please revert back


Starla Eve

Program Manager,

Oncology Conferences

Kemp House

152 City Road

London EC1V 2NX, UK

Tel: +1-702-508-5200 (8113)

Fax: +1-650-618-1417


Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.